60
Participants
Start Date
November 14, 2022
Primary Completion Date
June 30, 2024
Study Completion Date
June 30, 2024
Coronary computed tomography angiography
CT scan of the heart arteries
Invasive coronary angiography
Invasive coronary angiography via the radial or femoral approach
Transthoracic echocardiography
Ultrasound scan of the heart
Cardiac MRI scan
An MRI scan to assess the heart structure and function
Antiplatelet Drug (Aspirin or Statin)
Antiplatelet therapy for coronary artery disease
Anticoagulants (Apixaban, Edoxaban, Rivaroxoban, Warfarin)
Anticoagulant therapy if atrial fibrillation identified (DOAC or Warfarin)
Guideline directed heart failure therapy
Use of guideline approved heart failure treatments (ACE-inhibitor / angiotensin receptor blocker (ARB) / ARB and neprilysin inhibitor, mineralocorticoid receptor antagonist, beta blocker, SGLT-2 inhibitor, diuretic therapy)
Statins (Cardiovascular Agents)
Statins will be recommended for patients with coronary plaque disease or hypercholesterolaemia
Victoria Hospital, Kirkcaldy
NHS Lothian, Edinburgh
Chief Scientist Office of the Scottish Government
OTHER_GOV
University of Edinburgh
OTHER